Skip to content
Disability, Medical Health Aged Care

Strengths-based research offers inspiration for autistic people

UNSW Sydney < 1 mins read

A new project from UNSW brings to light creative ways autistic people support their wellbeing.

A new autistic-led project, Autism Supports for Comfort, Care, and Connection, reveals the everyday and creative ways autistic adults use objects, services, and creatures to support their wellbeing.

Conducted by Dr Megan Rose, research fellow, and Prof Deborah Lupton, from the ARC Centre of Excellence for Automated Decision-Making and Society at UNSW, the study interviewed 12 autistic Australians about the supports they rely on for entertainment, social connection, special interests, burnout recovery, sensory challenges, and overall wellbeing.

Participants also imagined their ideal new support system tailored to their needs.


To visually represent these experiences, autistic graphic illustrator Sarah Firth was commissioned to create unique ‘portraits’ of each participant. Using anonymised interview transcripts, Sarah crafted illustrations that depict the challenges, coping strategies, and special interests of each individual—without ever seeing or meeting them.

The resulting booklet combines these portraits with lay-language participant narratives, offering a powerful and personal look at how autistic people engage with non-human supports in their daily lives.

“Importantly, this is an autistic-led project with a strengths-based approach. Megan and I wanted to focus on identifying not only the challenges faced by autistic people, but also the amazingly inventive ways they made their lives more comfortable and joyful,” Professor Lupton said.

 
 

Key Facts:

The full report can be found at https://apo.org.au/node/330234.


Contact details:

Professor Lupton is available for interview.
Contact:
Samantha Dunn

UNSW News & Content 
(02) 9065 5455
[email protected]

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.